| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,912 |
1,631 |
$89K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,056 |
954 |
$83K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
377 |
221 |
$29K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
396 |
327 |
$28K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
295 |
265 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
476 |
440 |
$20K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,016 |
882 |
$18K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
123 |
119 |
$17K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
98 |
67 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
51 |
46 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
36 |
29 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
118 |
113 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
50 |
49 |
$3K |
| 96127 |
|
106 |
94 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
82 |
71 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
16 |
$500.80 |
| 87081 |
|
37 |
32 |
$214.60 |
| 91307 |
|
13 |
12 |
$0.01 |
| 1220F |
|
26 |
26 |
$0.00 |
| 1036F |
|
26 |
26 |
$0.00 |
| 99072 |
|
146 |
130 |
$0.00 |
| 1003F |
|
304 |
218 |
$0.00 |